Mirae Asset Global Investments Co., Ltd. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,128,786
-7.6%
134,139
+9.8%
0.01%0.0%
Q2 2023$2,304,294
+311.5%
122,163
-16.2%
0.01%
+400.0%
Q1 2023$559,926
+19.9%
145,814
+54.9%
0.00%0.0%
Q4 2022$466,875
+4.0%
94,128
+0.1%
0.00%0.0%
Q3 2022$449,000
+49.7%
94,050
+40.8%
0.00%0.0%
Q2 2022$300,00066,7970.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders